Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40

被引:155
作者
Hardy, S
St-Onge, GG
Joly, É
Langelier, Y
Prentki, M
机构
[1] Univ Montreal, Ctr Hosp, Ctr Rech, Mol Nutr Unit, Montreal, PQ H2L 4M1, Canada
[2] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
[3] Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada
[4] Univ Montreal, Dept Nutr, Montreal, PQ H2L 4M1, Canada
[5] Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ H2L 4M1, Canada
关键词
D O I
10.1074/jbc.M410922200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evidence from epidemiological studies and animal models suggests a link between high levels of dietary fat intake and risk of breast cancer. In addition, obesity, in which circulating lipids are elevated, is associated with increased risk of various cancers. Relative to this point, we previously showed that oleate stimulates the proliferation of breast cancer cells and that phosphatidylinositol 3-kinase plays a role in this process. Nonetheless, questions remain regarding the precise mechanism(s) by which oleate promotes breast cancer cell growth. Pharmacological inhibitors of the GTP-binding proteins G(i)/G(o), phospholipase C, Src, and mitogenic-extracellular signal-regulated kinase 1/2 (MEK 1/2) decreased oleate-induced [H-3]thymidine incorporation in the breast cancer cell line MDA-MB-231. In addition, oleate caused a rapid and transient rise in cytosolic Ca2+ and an increase in protein kinase B phosphorylation. Overexpressing in these cells the G protein-coupled receptor GPR40, a fatty acid receptor, amplified oleate-induced proliferation, whereas silencing the GPR40 gene using RNA interference decreased it. Overexpressing GPR40 in T47D and MCF-7 breast cancer cells that are poorly responsive to oleate allowed a robust proliferative action of oleate. The data indicate that the phospholipase C, MEK 1/2, Src, and phosphatidylinositol 3-kinase/protein kinase B signaling pathways are implicated in the proliferative signal induced by oleate and that these effects are mediated at least in part via the G protein-coupled receptor GPR40. The results suggest that GPR40 is implicated in the control of breast cancer cell growth by fatty acids and that GPR40 may provide a link between fat and cancer.
引用
收藏
页码:13285 / 13291
页数:7
相关论文
共 55 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] MEMBRANE PARTITION OF FATTY-ACIDS AND INHIBITION OF T-CELL FUNCTION
    ANEL, A
    RICHIERI, GV
    KLEINFELD, AM
    [J]. BIOCHEMISTRY, 1993, 32 (02) : 530 - 536
  • [3] WORTMANNIN IS A POTENT PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR - THE ROLE OF PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE IN NEUTROPHIL RESPONSES
    ARCARO, A
    WYMANN, MP
    [J]. BIOCHEMICAL JOURNAL, 1993, 296 : 297 - 301
  • [4] Boney CM, 2001, CELL GROWTH DIFFER, V12, P379
  • [5] Advances in protein kinase B signalling:: AKTion on multiple fronts
    Brazil, DP
    Yang, ZZ
    Hemmings, BA
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (05) : 233 - 242
  • [6] The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
    Briscoe, CP
    Tadayyon, M
    Andrews, JL
    Benson, WG
    Chambers, JK
    Eilert, MM
    Ellis, C
    Elshourbagy, NA
    Goetz, AS
    Minnick, DT
    Murdock, PR
    Sauls, HR
    Shabon, U
    Spinage, LD
    Strum, JC
    Szekeres, PG
    Tan, KB
    Way, JM
    Ignar, DM
    Wilson, S
    Muir, AI
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) : 11303 - 11311
  • [7] Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor
    Buteau, J
    Foisy, S
    Joly, E
    Prentki, M
    [J]. DIABETES, 2003, 52 (01) : 124 - 132
  • [8] Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
    Calle, EE
    Kaaks, R
    [J]. NATURE REVIEWS CANCER, 2004, 4 (08) : 579 - 591
  • [9] CHIJIWA T, 1990, J BIOL CHEM, V265, P5267
  • [10] COLEMAN RA, 1994, PHARMACOL REV, V46, P205